Immunotherapy for Metastatic Kidney Cancer Shows Increased Survival
2 विचारों
administrator
07/10/23
The immune checkpoint inhibitor Opdivo (nivolumab) has been shown to increase survival for patients with metastatic clear cell kidney cancer (also called renal cell carcinoma, or RCC).
और दिखाओ
फेसबुक टिप्पणियाँ
कोई टिप्पणी नहीं मिली